September 16, 2026

Creatine Supplementation and Resistance Training: What the Evidence Shows for Sarcopenic Obesity

By Dr. Zakira Naureen
Nutrition Exercise Body Composition

In Simple Terms

  • Does taking creatine actually build muscle, or is that just gym folklore?
  • Why nearly all of the strong evidence comes from adults over fifty, not people in their twenties
  • Whether creatine helps you lose fat too, or only adds muscle
  • What the research actually says about kidney safety, since that is most people's first worry
  • Why no study has yet tested creatine specifically in people diagnosed with sarcopenic obesity

Creatine monohydrate is one of the most heavily studied supplements in sports science, and it has a reputation as a muscle builder for gym goers. What gets discussed far less is what the trial evidence actually shows when creatine is paired with resistance training in adults who are losing muscle, and whether any of that evidence applies to sarcopenic obesity specifically. It is a useful case study in how promising a supplement can look in aggregate while still leaving real gaps for the exact population a website like this one is trying to reach.

What creatine actually does inside muscle

Creatine is stored in skeletal muscle mostly as phosphocreatine, a rapidly available reserve the body taps to regenerate ATP during short bursts of high intensity effort, such as the last few repetitions of a heavy set. Supplementing with three to five grams a day raises intramuscular creatine and phosphocreatine stores by roughly twenty percent, which lets a person push out a few more repetitions or a bit more load per set. Over months of training, that small per session advantage compounds into a meaningfully larger training stimulus.

Creatine also appears to act on muscle growth through a second, more direct pathway. It draws water into muscle cells, and this cell swelling is thought to act as an anabolic signal that upregulates protein synthesis and may also support satellite cell activity, the process by which muscle fibers recruit new nuclei to grow. Some of the early weight gain seen with creatine is water inside muscle tissue rather than new contractile protein, which is a normal and expected part of how it works, not a sign the supplement is doing nothing.

What the meta-analyses show for lean mass and strength

The clearest evidence comes from a 2025 systematic review and meta-analysis in the European Review of Aging and Physical Activity, which pooled eight randomized controlled trials of creatine plus resistance training against placebo plus resistance training in older adults. Creatine produced a small but statistically significant advantage in lean tissue mass and in lower limb strength. When the analysis was limited to trials lasting thirty two weeks or less, the advantage for both lean tissue mass and upper limb strength grew substantially larger and more consistent, suggesting the relative benefit of creatine may be strongest earlier in a training program and less pronounced over very long interventions.

This builds on an earlier, frequently cited 2014 meta-analysis in Medicine & Science in Sports & Exercise by Devries and Phillips, which found that creatine combined with resistance training increased fat free mass by roughly 1.3 kilograms more than resistance training with a placebo, across a pooled sample of several hundred older adults training for around twelve weeks, along with measurable strength gains on chest press and leg press. Taken together, these two analyses, published a decade apart, point in the same direction: creatine adds a modest but real amount of extra lean mass and strength on top of what resistance training achieves alone, at least in adults over fifty.

Does creatine help with fat loss too?

This is where the evidence gets more equivocal, and worth stating honestly rather than rounding up. A 2019 meta-analysis pooling nineteen studies and over six hundred adults aged fifty and older found that creatine plus resistance training reduced body fat percentage slightly more than resistance training with a placebo, by about half a percentage point. The equivalent difference in absolute fat mass, roughly half a kilogram in creatine's favor, did not reach statistical significance. In plain terms, creatine is not a fat loss supplement. Any fat related benefit appears to be a secondary consequence of building more muscle and being able to train a bit harder, not a direct effect on fat tissue itself, and the effect size involved is small.

The evidence gap: sarcopenic obesity and young adults

Almost every trial described above was conducted in people over fifty, most without a formal sarcopenia or sarcopenic obesity diagnosis. A 2021 review in Nutrients by Candow and colleagues states this gap plainly: evidence for creatine's efficacy in older adults with sarcopenia is already limited, and at the time of that review, no controlled trials existed in older adults with osteosarcopenia, sarcopenic obesity, physical frailty, or cachexia specifically. That gap has not been meaningfully closed since. For a website built around research on sarcopenic obesity in young Omani adults, this is an important caveat rather than a footnote: the creatine literature is built almost entirely on a different age group and, largely, on people without the specific combination of low muscle mass and excess fat that defines this condition.

It is also worth being clear that creatine is not a substitute for resistance training itself. The same Nutrients review points to a large, two year randomized trial of creatine given without any structured resistance training in postmenopausal women, which found no meaningful effect on lean mass, muscle strength or function, bone density, or fracture risk. The muscle building effect of creatine documented in the meta-analyses above is consistently a creatine plus training effect, not something creatine produces reliably on its own. Readers who are inactive should not expect a supplement to substitute for the exercise stimulus discussed in our piece on resistance training volume and dose response.

Is creatine safe? The kidney question

Concern about kidney strain is the most common reason people hesitate to try creatine, and it is a reasonable question to ask before adding any supplement. A 2025 systematic review and meta-analysis in BMC Nephrology, pooling data from a dozen or more studies, found a very small statistically significant rise in serum creatinine among creatine users, an average difference of well under a tenth of a micromole per liter. Critically, the same analysis found no significant change in estimated glomerular filtration rate, the more direct marker of actual kidney function, and the authors attributed the small creatinine rise to increased creatine to creatinine metabolic turnover rather than any sign of kidney damage. For people with pre-existing kidney disease, a conversation with a physician before supplementing is still sensible, since that population was not well represented in these trials, but for otherwise healthy adults at standard doses the evidence does not support the idea that creatine harms kidney function.

Practical implications

For a healthy adult already doing resistance training, the trial evidence supports a daily maintenance dose of roughly three to five grams of creatine monohydrate, taken any time of day, with no requirement for the higher dose loading phase some marketing suggests, though loading does reach saturation faster if someone wants that. The benefit shows up as a small addition on top of a real resistance training program, not as a replacement for one, and the strength and lean mass gains described here were all measured alongside structured strength training, typically two to three sessions per week. Whole food sources such as red meat and fish contain creatine, but in amounts far below what supplementation provides, which is why dietary intake alone does not replicate the doses used in these trials. None of this changes the more fundamental prevention steps covered in our complete guide for young adults, which remain resistance training, adequate protein, and reducing sedentary time. Creatine, where the evidence exists, is best understood as a small add on to those fundamentals rather than a stand-in for them, and protein intake itself carries its own nuances worth reading in our piece on the protein paradox.

Limitations and what we still do not know

Several limits are worth carrying forward. The trial base is concentrated in adults fifty and older, so how creatine performs in younger adults with early signs of sarcopenic obesity, the population this project is specifically studying, has not been directly tested. Trial durations in the meta-analyses above ranged mostly from three to twelve months, so long term effects over years remain uncertain, and the apparent decline in relative benefit in longer trials needs replication. Study sizes, while collectively reaching several hundred to over a thousand participants across pooled analyses, are still small by the standards of pharmaceutical trials, and most trials were not designed around fat mass as a primary outcome, which limits confidence in the modest fat percentage finding. Finally, no trial to date has enrolled participants specifically diagnosed with sarcopenic obesity by current ESPEN and EASO consensus criteria, so everything here is an informed extrapolation from a related but distinct population, not a direct answer.

This post is for general education and is not medical advice. Speak with a healthcare provider, particularly if you have existing kidney disease, before starting any new supplement.

References

← Back to all posts